Recent News

  • Flawed studies informed recommendations against CYP2D6 testing for tamoxifen treatment, new study findsA recent Mayo Clinic study has found that clinical recommendations discouraging the use of CYP2D6 genetic testing to advise tamoxifen treatment in women with breast cancer should be reconsidered because some of the studies the recommendations were based on had flawed methodology. The article, published in the January issue of ...Read More
  • What President Obama’s precision medicine push could mean for the field of pharmacogenomicsBy Josh Schwartz Each year the President of the United States goes before Congress to present a report on the State of the Union. The range of topics covered in this address is typically quite broad, but one of the president’s newest initiatives stood out among the others: Precision Medicine. ...Read More